QUALIFY Life Sciences
Annual accounts 2025
micro format, filed on 30-07-2026, 1 day before the deadlineTurnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €2.7m. Estimated: probably between €1.8m and €3.5m.
Balance sheet
balance sheet total €1.3m on 31-12-2025in euro
in euro
Position in the sector
31.2%
Higher than 31% of 39,368 companies in 2025.
1.40
Higher than 37% of 38,051 companies in 2025.
26.1%
Higher than 66% of 38,523 companies in 2025.
Net result: top quarter · Equity: top quarter · Balance sheet total: top quarter · Working capital: top quarter
Staff
€72,380
Staff costs divided by the average number of full-time equivalents.
+10 people
In 2025, 24 people joined and 14 left. Training hours in 2025: 176.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
1.3m | 347,451 | |
21/28 |
127,343 | 18,499 | |
22/27 |
121,401 | 16,749 | |
23 |
1,147 | - | |
24 |
111,577 | 12,943 | |
26 |
8,677 | 3,806 | |
28 |
5,942 | 1,750 | |
29/58 |
1.2m | 328,952 | |
29 |
- | 25,000 | |
291 |
- | 25,000 | |
40/41 |
805,107 | 163,946 | |
40 |
805,107 | 163,946 | |
54/58 |
363,181 | 136,232 | |
490/1 |
- | 3,774 | |
| Balance sheet: equity and liabilities | |||
10/49 |
1.3m | 347,451 | |
10/15 |
404,613 | 66,893 | |
10/11 |
9,000 | 9,000 | |
14 |
395,613 | 57,893 | |
17/49 |
891,017 | 280,558 | |
17 |
56,248 | 108,500 | |
170/4 |
56,248 | 108,500 | |
42/48 |
834,769 | 172,058 | |
42 |
18,294 | - | |
44 |
419,972 | 100,492 | |
440/4 |
419,972 | 100,492 | |
45 |
394,256 | 68,670 | |
450/3 |
328,771 | 54,178 | |
454/9 |
65,484 | 14,492 | |
47/48 |
2,247 | 2,896 | |
| Income statement | |||
9900 |
1.5m | 203,288 | |
62 |
984,367 | 124,506 | |
630 |
19,950 | 1,976 | |
640/8 |
7,121 | 1,838 | |
9901 |
478,407 | 74,968 | |
75/76B |
- | 1 | |
75 |
- | 1 | |
65/66B |
9,788 | 1,076 | |
65 |
9,788 | 1,076 | |
9903 |
468,618 | 73,893 | |
67/77 |
130,898 | 16,000 | |
9904 |
337,721 | 57,893 | |
9905 |
337,721 | 57,893 | |
| Appropriation of the result | |||
9906 |
395,613 | 57,893 | |
14P |
57,893 | - | |
| Social balance sheet | |||
9087 |
13.6 | 3.9 | |
Hours worked1013 |
23,336 | 3,248 | |
| Document | |||
The notes to these accounts have 9 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 30-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankKey figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| 498,357 | 76,944 | ||
| 357,671 | 59,869 | ||
| 150,774 | 20,475 | ||
| 226,949 | - | ||
| 333,519 | 156,894 | ||
| 31.2% | 19.3% | ||
| 1.40 | 1.91 | ||
| 2.20 | 4.19 | ||
| 83.5% | 86.5% | ||
| 26.1% | 16.7% | ||
| 50.91 | 71.51 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Social balance sheet
| Item | 31-12-2025 | 31-12-2024 |
|---|---|---|
| Employees at the balance-sheet date | 16 | 6 |
| full-time | 16 | 6 |
| in full-time equivalents | 16 | 6 |
| 13.6 | 3.9 | |
| On a permanent contract | 16 | 6 |
| Joined | 24 | 7 |
| Left | 14 | 1 |
| Training hours | 176 | - |
Source: social balance sheet in the 2024 to 2025 annual accounts
Investments
fixed assets acquired| Item | 2025 | 2024 |
|---|---|---|
| Tangible fixed assets | €146,582 | €18,725 |
| Financial fixed assets | €4,192 | €1,750 |
| €19,950 | €1,976 |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
Insights on QUALIFY Life Sciences
The operating result for 2025 is 6.4 times that of 2024.
Debt's share of the balance-sheet total falls from 80.7% to 68.8%. Equity and debt are higher.